Loading
Donate

Utah CBD-Specific Marijuana Law

Status

 

CBD Specific

Law Signed:

2014

QUALIFYING CONDITIONS

  • Intractable epilepsy
  • Terminally ill patients (Under legislation signed in 2018, a patient diagnosed with no more than six months to live may access cannabis-infused products produced by a state-licensed provider.)

PATIENT POSSESSION LIMITS

Cannabis extracts that contain more than 15 percent CBD and no more than 0.3 percent THC

HOME CULTIVATION

No

STATE-LICENSED DISPENSARIES

No. However, legislation signed in 2018 seeks to permit the production and manufacturing of CBD-infused products to be sold at "cannabidiol-qualified pharmacies." These products must contain a 10 to 1 ratio of CBD to THC and are only to be sold to patients who possess a doctor's recommendation to use CBD. Separate legislation, also signed into law in 2018, permits the Department of Agriculture and Food to contract with a third party to cultivate cannabis for the purpose of manufacturing marijuana-infused oils and other related products. These products would be provided to terminally ill patients and also used in state-sponsored research trials.

CAREGIVERS

No

RECIPROCITY

No

CONTACT INFORMATION